Park Ha Biological Technology Co., Ltd. (PHH)
Park Ha Biological Technology will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $6.00
Shares Offered
1,200,000
Deal Size
$6.00M
PHH Revenue
Park Ha Biological Technology had revenue of $1.94M in the twelve months ending April 30, 2024. In the fiscal year ending October 31, 2023, Park Ha Biological Technology had annual revenue of $2.46M with 28.12% growth.
Revenue (ttm)
$1.94M
Revenue Growth
+28.12%
P/S Ratio
67.51
Revenue / Employee
$58,801
Employees
33
Market Cap
131.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2023 | 2.46M | 539.71K | 28.12% |
| Oct 31, 2022 | 1.92M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPHH News
- 7 weeks ago - Park Ha Biological Aims For U.S. IPO At Sky-High Valuation - Seeking Alpha
- 4 months ago - U.S. IPO Weekly Recap: Small Issuers Close Out August IPO Market - Seeking Alpha
- 4 months ago - Chinese skincare product company Park Ha Biological Technology files and sets terms for a $7 million US IPO - Renaissance Capital
- 4 months ago - Park Ha Biological Technology IPO Registration Document (F-1) - SEC